Immunofluorescent staining of beta-catenin revealed significantly higher expressions in the renal tubules of the CIS-treated Gal-3 wild mice compared to Gal-3 wild-type sham control mice (p < 0.001) (Figure 13A,B,E). The gene discussed is CTNNB1; the disease is in situ carcinoma.